Companies Dominating the Narcolepsy Drugs Landscape
- Ligand Pharmaceuticals Incorporated
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Jazz Pharmaceuticals Inc.
- Graymark Healthcare Inc.
- BIOPROJET
- Novartis AG
- Teva Pharmaceuticals Industries Ltd.
- Arena Pharmaceuticals Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of narcolepsy drugs is assessed at USD 4.67 billion.
The narcolepsy drugs market size was over USD 4 billion in 2024 and is anticipated to cross USD 13.97 billion by 2037, growing at more than 10.1% CAGR during the forecast period i.e., between 2025-2037. The rising prevalence of narcolepsy globally owing to the stressful lifestyle along with the surge in consumption of alcohol and tobacco will drive the market growth.
North America industry is predicted to hold largest revenue share by 2037, owing to rising prevalence of unhealthy lifestyles along with the technological advancements for the diagnosis of disease.
The major players in the market are Ligand Pharmaceuticals Incorporated, Jazz Pharmaceuticals Inc., Graymark Healthcare Inc., BIOPROJET, Novartis AG, Teva Pharmaceuticals Industries Ltd., Arena Pharmaceuticals Inc.
